Biotech · Private company · Germantown, MD, US
Barinthus Biotherapeutics plc.
SEC CIK 0001828185
Track this companyFree. Adds Barinthus Biotherapeutics plc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ChAdOx1-PCAQPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- MVA-PCAQPhase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- VTP-1000Phase 1 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- VTP-1000 in Adults With Celiac DiseaseEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Aug 1, 2024ClinicalTrials.gov NCT06310291 · fetched Nov 12, 2026
- Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerPHASE1_PHASE2 · TERMINATED · started Jan 30, 2023ClinicalTrials.gov NCT05617040 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Sep 9, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 1, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 25, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 2, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 22, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 13, 2026 · fetched Nov 12, 2026